FDA Puts Immucor On Notice For Safety Violations

Law360, New York (May 14, 2008, 12:00 AM EDT) -- The U.S. Food and Drug Administration has warned Immucor Inc. of severe regulatory action after numerous product safety violations were found at a facility of the medical equipment manufacturer.

FDA Enforcement Director David K. Elder sent Immucor a formal warning letter on May 2.

The document, which the FDA made public Tuesday, outlines several alleged violations of the Food, Drug & Cosmetic Act and gives Immucor 15 business days either to resolve them or to explain in writing why it needs more time.

“Failure to promptly...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.